nygazet.com logo
Merck (MRK) earnings Q3 2025
business

Merck (MRK) earnings Q3 2025

1 min read

Merck said its narrowed profit guidance reflects several new items, including "lower estimated costs related to the impact of tariffs."

Merck on Thursday reported third-quarter earnings and revenue that topped estimates as it saw strong demand for its cancer immunotherapy Keytruda. The drugmaker also narrowed its full-year profit outlook to reflect lower estimated tariff costs, among... [2678 chars]

Read Original Article

Source: CNBC

Visit Source

Share this article